ArticleGut and liver2019

Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma.

Bo Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.